Robotic versus open pelvic exenterations for pelvic cancer - a multicenter propensity-matched analysis in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230163

Enrollment

449

Registered

2023-06-24

Start date

2023-04-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic cancer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who underwent total pelvic exenteration (TPE), Anterior pelvic exenteration (APE), posterior pelvic exenteration (PPE) for pelvic malignant tumor between January 2012 and October 2022 were included.

Exclusion criteria

Exclusion criteria: Those patients who did not diagnosed as a histologically malignant, who had not been of declared of their cancer, or who refused to participate in the study were excluded.

Design outcomes

Primary

Measure	Time frame
the complication rate of over C-D grade IIIA	—

Secondary

Measure	Time frame
Duration of operation (min), Intraoperative blood loss (ml), Intraoperative transfusion, Resection margin status,Conversion to open surgery, In-hostital death, Death within 30 days, Morbidity within 30 days, Morbidity within 90days	—

Contacts

Public ContactYusuke Yatabe

Tokyo Medical and Dental University

yatabe.srg1@tmd.ac.jp+81-3-5803-5254

Outcome results